Growing community of inventors

Sakura, Japan

Takuo Aoyama

Average Co-Inventor Count = 7.79

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 67

Takuo AoyamaToyoo Nakayama (5 patents)Takuo AoyamaToshiyuki Okutome (5 patents)Takuo AoyamaShigeki Nunomura (5 patents)Takuo AoyamaMasateru Kurumi (5 patents)Takuo AoyamaSetsuro Fujii (4 patents)Takuo AoyamaKimio Sudo (4 patents)Takuo AoyamaYojiro Sakurai (3 patents)Takuo AoyamaTakashi Yaegashi (2 patents)Takuo AoyamaShinichi Watanabe (2 patents)Takuo AoyamaShin-ichi Watanabe (2 patents)Takuo AoyamaSetsurou Fujii (2 patents)Takuo AoyamaHiroyuki Kawamura (1 patent)Takuo AoyamaRyoji Matsui (1 patent)Takuo AoyamaTakuo Sato (1 patent)Takuo AoyamaTakuo Aoyama (6 patents)Toyoo NakayamaToyoo Nakayama (13 patents)Toshiyuki OkutomeToshiyuki Okutome (11 patents)Shigeki NunomuraShigeki Nunomura (8 patents)Masateru KurumiMasateru Kurumi (7 patents)Setsuro FujiiSetsuro Fujii (69 patents)Kimio SudoKimio Sudo (9 patents)Yojiro SakuraiYojiro Sakurai (8 patents)Takashi YaegashiTakashi Yaegashi (12 patents)Shinichi WatanabeShinichi Watanabe (5 patents)Shin-ichi WatanabeShin-ichi Watanabe (2 patents)Setsurou FujiiSetsurou Fujii (2 patents)Hiroyuki KawamuraHiroyuki Kawamura (8 patents)Ryoji MatsuiRyoji Matsui (3 patents)Takuo SatoTakuo Sato (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Torii & Co., Ltd. (6 from 26 patents)


6 patents:

1. 4820730 - 6-amino-2-naphthyl 4-gusnichinobenzoate derivatives and pharmaceutical

2. 4777182 - 6-Amidino-2-naphthyl 4-guanidinobenzoate derivatives and pharmaceutical

3. 4634783 - Novel amidine compound

4. 4598077 - Amidine derivatives and cardiotonic compositions

5. 4563527 - Amidine compounds

6. 4490388 - Amidine compound and anticomplement agent comprising same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/4/2026
Loading…